Continuing clozapine treatment after a diagnosis of cardiomyopathy
F Williams1, F Lenihan2, A Rowe3
1NHS Fife, Learning Disability Service, Lynebank Hospital, Dunfermline, Halbeath, Fife, UK.
Insights
Clozapine, a crucial antipsychotic for treatment-resistant schizophrenia, can cause cardiac issues. This case highlights managing cardiomyopathy by continuing clozapine with cardiac medication, avoiding psychosis relapse.
Area of Science:
- Psychiatry
- Cardiology
- Pharmacology
Background:
- Treatment-resistant schizophrenia presents significant management challenges.
- Clozapine is highly effective but carries risks, including cardiac side effects.
- Patient history of violence and treatment resistance complicated management decisions.
Purpose of the Study:
- To describe the management of a patient with treatment-resistant schizophrenia and clozapine-induced cardiomyopathy.
- To evaluate the risk-benefit of continuing clozapine versus managing psychosis exacerbation.
- To illustrate a multidisciplinary approach involving psychiatry and cardiology.
Main Methods:
- Case report of a patient with schizophrenia on clozapine.
- Diagnosis of sustained tachycardia and mild biventricular cardiomyopathy via echocardiography.
- Pharmacological management including ramipril and bisoprolol, alongside continued clozapine therapy.
Main Results:
- The patient's cardiomyopathy was mild and did not necessitate clozapine discontinuation.
- Continuing clozapine, with added cardiac medications, successfully managed both psychosis and cardiac function.
- The patient was successfully discharged from psychiatric care and maintained on clozapine.
Conclusions:
- Careful risk-benefit assessment is crucial when managing clozapine's cardiac side effects in patients with severe mental illness.
- Continuing clozapine may be preferable to antipsychotic withdrawal if cardiac risks are manageable.
- A collaborative approach between psychiatry and cardiology can optimize patient outcomes.
Abstract:
A patient in a medium secure psychiatric unit with a 19-year history of treatment-resistant schizophrenia and violence whose mental illness only responded to clozapine, was noted to have a sustained tachycardia. Echocardiography revealed mild biventricular cardiomyopathy. The patient was not significantly affected by this. Initial recommendation from Cardiology was to consider discontinuation of clozapine. It was decided, however, that the risk of worsening psychosis and resultant violence outweighed the risk of the patient's relatively mild cardiomyopathy. The patient was commenced on ramipril, and later bisoprolol. The patient no longer requires treatment in a medium secure unit and has remained on clozapine with follow-up from cardiology.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis IV: Nursing Management
Cardiomyopathy VI: Nursing Management


